This trial will evaluate if enhancing sleep, either alone or along with other activities that impact self-regulatory pathways related to sleep, can help prevent obesity in children.
1 Primary · 11 Secondary · Reporting Duration: Change from baseline in MVPA at 6 months
204 Total Participants · 2 Treatment Groups
Primary Treatment: Optimize Sleep (OS) · No Placebo Group · N/A
Age 6 - 11 · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: